A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01900106
Recruitment Status : Recruiting
First Posted : July 16, 2013
Last Update Posted : October 27, 2016
Information provided by (Responsible Party):
Cristina Mussini, University of Modena and Reggio Emilia

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2016